Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
Eli Lilly and Co. announced today that CEO John Lechleiter will also gain the additional title of chairman on Jan. 1.
Lechleiter will replace Sidney Taurel, who is retiring.
Lechleiter took over for Taurel as CEO on April 1. Lilly directors today also named Taurel as chairman emeritus.
Please enable JavaScript to view this content.
Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.